Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christopher John Hood"'
Publikováno v:
Kidney International Reports, Vol 2, Iss 4, Pp 705-712 (2017)
Metformin use in advanced chronic kidney disease is controversial. This study sought to examine the pharmacokinetics, safety, and efficacy of low-dose metformin in patients with type 2 diabetes and stage 4 chronic kidney disease. Methods: In this ope
Externí odkaz:
https://doaj.org/article/6171c9205168467792c4404a56a67e5c
Autor:
Joanna L. Dunlop, Alain C. Vandal, Ruvin Gabriel, Kannaiyan Samuel Rabindranath, John B. W. Schollum, David O. McGregor, Janak de Zoysa, Philip James Matheson, Mark R. Marshall, David Semple, Tian Min Ma, John Irvine, Imad Adbi Haloob, Rose Sisk, Zhengxiu Xie, Christopher John Hood
Publikováno v:
J Am Soc Nephrol
Background Fluid overload in patients undergoing hemodialysis contributes to cardiovascular morbidity and mortality. There is a global trend to lower dialysate sodium with the goal of reducing fluid overload. Methods To investigate whether lower dial
Publikováno v:
Nephrology. 20:250-256
Background Currently available calcium- and aluminium-based phosphate binders are dose limited because of potential toxicity, and newer proprietary phosphate binders are expensive. We examined phosphate-binding effects of the bile acid sequestrant co
Publikováno v:
Pharmacology Research & Perspectives
The pharmacokinetics of metformin therapy in patients with chronic kidney disease stage 4 (CKD‐4) were studied using data from the largest Phase I consecutive cohort trial yet performed in this population. Eighteen metformin‐naïve men and women
Autor:
Alain C. Vandal, Joanna L. Dunlop, Christopher John Hood, Ruvin Gabriel, David Semple, Kannaiyan Samuel Rabindranath, Philip James Matheson, Janak de Zoysa, David O. McGregor, Imad Adbi Haloob, Mark R. Marshall
Publikováno v:
BMC Nephrology
After the publication of our paper Dunlop et al. “Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left
Autor:
Ruvin Gabriel, Kannaiyan Samuel Rabindranath, Imad Adbi Haloob, David O. McGregor, Lukas Mathias Gerber, Alain C. Vandal, John Irvine, Joanna L. Dunlop, Janak de Zoysa, John Benedict William Schollum, Philip James Matheson, Mark R. Marshall, David Semple, Christopher John Hood
Publikováno v:
BMC Nephrology
Background The Sodium Lowering in Dialysate (SoLID) trial is an ongoing a multi-center, prospective, randomised, single-blind (assessor), controlled, parallel assignment clinical trial, enrolling 96 home and self-care hemodialysis (HD) patients from
Autor:
David O. McGregor, Mark R. Marshall, Joanna L. Dunlop, David Semple, Imad Adbi Haloob, Philip James Matheson, Janak de Zoysa, Alain C. Vandal, Ruvin Gabriel, Kannaiyan Samuel Rabindranath, Christopher John Hood
Publikováno v:
BMC Nephrology
Background The current literature recognises that left ventricular hypertrophy makes a key contribution to the high rate of premature cardiovascular mortality in dialysis patients. Determining how we might intervene to ameliorate left ventricular hyp
Publikováno v:
BMC Nephrology, Vol 13, Iss 1, p 28 (2012)
BMC Nephrology
BMC Nephrology
Background Home hemodialysis is common in New Zealand and associated with lower cost, improved survival and better patient experience. We present the case of a fully trained home hemodialysis patient who exsanguinated at home as a result of an incorr